IBX 2.56% 3.8¢ imagion biosystems limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-14

  1. 92 Posts.
    lightbulb Created with Sketch. 58
    26 May 2021
    First-in-human study update: First patient enrolled
    MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare
    through the earlier detection of cancer, is pleased to announce that the first patient has been enrolled in the
    MagSense® HER2 breast cancer Phase I first-in-human study.

    Note that this was a market sensitive relase so why not now with "multiple patients"?
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $1.329M
Open High Low Value Volume
3.8¢ 3.8¢ 3.8¢ $2.593K 68.23K

Buyers (Bids)

No. Vol. Price($)
1 32255 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 6078 1
View Market Depth
Last trade - 10.15am 06/08/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.